Hannah W Irving, MD

Dr. Hannah Walters is a board-certified neurologist and is a fellowship-trained movement disorders specialist. She joined the Inova Health System in 2020 and has been practicing since 2014. Dr. Walters specializes in the management of Parkinson’s disease, Huntington’s disease, essential tremor, dystonia, ataxia, tic disorders and other movement disorders. She has specialized training in the use of botulinum toxin injections and deep brain stimulation (DBS) for movement disorders. She became interested in neurology and movement disorders after seeing the impact that quality care could have on a patient's life. She is especially interested in teaming with her patients as they progress through their disease journey to create a care plan incorporating cutting-edge pharmacology and technology with compassion and a focus on individual patient goals and needs. A native of rural Indiana, Dr. Walters currently resides in Reston, VA, with her significant other. She enjoys fine wine, hiking, board games and is a dog lover. Prior to adopting her current rescue dog, she was active in dog rescue and has fostered more than 30 animals. Memberships/Accreditations International Parkinson and Movement Disorder Society American Academy of Neurology Publications Walters H, Shah BB. Focused Ultrasound and Other Lesioning Therapies in Movement Disorders. Curr Neurol Neurosci Rep. 2019;19(9):66. Published 2019 Aug 3. doi:10.1007/s11910-019-0975-2. Kenofsky B, Youn C, Walters H, Navis A, Boniece I. An interesting PRESentation of NMO. Multiple Sclerosis and Related Disorders. 2018 Oct: 163-164. Barnum CJ, Bhide N, Lindenbach D, Surrena MA, Goldenberg AA, Tignor S,Klioueva A, Walters H, Bishop C. Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats. Pharmacol Biochem Behav. 100(3):607-15, 2012 Jan. Ostock CY, Dupre KB, Jaunarajs KL, Walters H, George J, Krolewski D, Walker PD, Bishop C. Role of the primary motor cortex in L-Dopa-induced dyskinesia and its modulation by 5-HT1A receptor stimulation. Neuropharmacology,61(4):753-60. 2011 Sep.